Clinical Trials Browser

Terminated × Pancreatic Neoplasms × Immunohistochemistry × Clear all

NCT00470535 2017-02-23

Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Phase 2 Terminated

18 enrolled 6 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2 Terminated

6 enrolled 8 charts

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms